Polar Capital’s Medicines Co MDCO Stock Holding History

Polar Capital’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-233,986	Closed	-$8.74M	–	288
2015 Q4	$8.74M	Buy	+233,986	New	+$8.84M	0.16%	147

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Polar Capital's MDCO Position: Q1 2016 in Review

Polar Capital sold out of Medicines Co (MDCO) in Q1 2016, closing a stake of 233,986 shares — an estimated $8.74M sold.

Polar Capital first reported a position in MDCO in Q4 2015 and held it in 1 quarter. The position peaked at $8.74M in Q4 2015. 181 funds tracked by Wall St. Rank hold MDCO as of Q1 2016.

Polar Capital reported no remaining Medicines Co position as of Q1 2016 after selling out during the quarter.
Polar Capital sold 233,986 Medicines Co shares in Q1 2016, an estimated $8.74M.
Polar Capital first reported a position in Medicines Co in Q4 2015 and held it in 1 quarter.
Polar Capital's Medicines Co position peaked at $8.74M in Q4 2015.
181 funds tracked by Wall St. Rank held Medicines Co as of Q1 2016.

Based on Polar Capital's 13F filing for Q1 2016, filed 16 May 2016.